CA2700503C — Ocular implants and methods
Assigned to Alcon Inc · Expires 2016-05-24 · 10y expired
What this patent protects
An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye is described herein. An embodiment described herein comprises an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye, the implant comprising:…
USPTO Abstract
An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye is described herein. An embodiment described herein comprises an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye, the implant comprising: a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The implant may optionally comprise a therapeutic agent deposited on the body, such as an anti-glaucoma drug or a prostaglandin analog.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.